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ÖZET
Amaç: Sulfonylurea receptor 1 (SUR1) geni SUR1 protei-
nini kodlayarak glukozla indüklenen insülin sekresyonun-
da anahtar rolü oynar. Bu çalışmanın amacı, SUR1 geninin 
31. ekzonundaki polimorfizm ile Tip 2 diyabet arasındaki 
ilişkiyi ve diyabetik hastalardaki obezite ile beraberliğini 
araştırmaktır.
Gereç ve yöntem: Diyabet polikliniğinde takip edilen 90 
hasta (45 kadın, 45 erkek ) çalışmaya dahil edildi. Serumda 
glukoz, trigliserid, kolesterol ve tam kanda HbA1c değer-
leri belirlendi. 31. Egzondaki SNP’ler ise polymeraz zincir 
reaksiyon / restriksiyon fragment uzunluk polymorphism 
(PCR-RFLP) yöntemiyle belirlendi.
Bulgular: Kontrol grubu ile karşılaştırıldığında Tip 2 diya-
betik hastalarda A allel frekansının artmış olduğu gözlendi 
(%41 ve %24, p<0.01), ve bu ilişkinin obez alt grupta daha 
belirgin olduğu gözlendi (A allele %44, p<0.01). Hasta ve 
kontrol grubu arasında 31. Ekzonun R1273R tek nükleo-
tit polimorfiziminde genotip dağılımında obez alt grupta 
daha fazla olmak üzere (p=0.007) anlamlı fark bulundu 
(p=0.01). 
Sonuç: SUR1 geninin 31. Ekzonundaki tek nükleotit po-
limorfizminin Türk tip 2 diyabet hastalarında ve obez alt 
grupta önemli rol aldığı söylenebilir. Klin Deney Ar Derg 
2011;2(2):161-7
Anahtar kelimeler: Tip 2 diyabet, obezite, SUR1 gen po-
limorfizmi, RFLP
ABSTRACT
Objectives: Sulfonylurea receptor 1 (SUR1) gene codes 
the SUR1 protein that plays a key role in glucose-induced 
insulin secretion. In this study, we have investigated the 
relationship between the polymorphism in exon 31 of the 
SUR1 gene and type 2 diabetes, and its association with 
obesity in Turkish diabetic patients.
Materials and methods: 90 patients (45 males and 45 
females, aged 43-70 years old) who were followed up in 
the diabetes outpatient clinic were enrolled in the study. 
Serum glucose, triglyceride, cholesterol and blood HbA1c 
levels were determined. The SNPs in exon 31 were exam-
ined by a polymerase chain reaction/restriction fragment 
length polymorphism (PCR-RFLP) method.
Results: A significant increase in the frequency of the A 
allele was observed in type 2 diabetic patients compared 
with that of the control group (41% vs. 24%, p<0.01), and 
this association was stronger in the subgroup of patients 
with obesity (A allele 44%, p<0.01). There was a significant 
difference in genotype distribution of exon 31 R1273R 
SNP between the patients and controls (P=0.01), espe-
cially between the patients with obesity and the control 
group (P=0.007).
Conclusion: This study reports that the SNP in exon 31 of 
the SUR1 gene is strongly associated with type 2 diabetes 
mellitus in Turkish patients with concomitant obesity, sug-
gesting interactions of SUR1 variants with type 2 diabetes 
and obesity. J Clin Exp Invest 2011;2(2):161-7
Key words: Type 2 diabetes, obesity, SUR1 gene polymor-
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INTRODUCTION
Diabetes  mellitus  (DM)  is  a  metabolic  disease 
caused by the absence of insulin or insulin resis-
tance that results in impaired insulin action charac-
terized with hyperglycemia.1 Thereby, the mecha-
nism of insulin secretion comes into prominence to 
clarify the etiology of DM. Adenosine triphosphate 
(ATP)-sensitive potassium (KATP) channels in pan-
creatic B-cells which are activated by glucose, regu-
late insulin secretion. In these cells, the increase in 
intracellular ATP concentration as a result of glu-
cose metabolism leads to closure of KATP chan-
nels. Closure of channels is followed by membrane 
depolarization, opening of voltage gated Ca2+ chan-
nels, intracellular Ca2+ flow and insulin exocytosis.2 
The KATP channels comprise two proteins: a pore 
forming Kir6.2 and a regulatory subunit, namely the 
SUR1 as an ATP sensor.3 The genes encoding these 
two subunits are located 4.5 kb apart on the human 
chromosome 11p15.1.4
It has previously been shown in newborns that 
the mutation in the genes encoding these two pro-
teins results in alterations of insulin secretion.5 Type 
2 diabetes is a multifactorial disease that combines 
hereditary  and  environmental  factors.6  It  is  also 
thought to be a polygenic disorder; that is, several 
defective genes are involved in the process.7 When 
the genes encoding the steps of the insulin secretion 
were investigated, a correlation was found between 
SNPs in the SUR1 gene and type 2 DM in different 
populations.8,10 However, even there is no threshold 
value for phenotypic differences; there is a firm cor-
relation between insulin response to oral glucose 
load in nondiabetic subjects and the SNP which is 
located in exon 31 of the SUR1 gene.11 The presence 
of the SNP at the same location in type 2 DM has 
brought about the need to make similar studies in 
different communities.12
In this study, we investigated the presence of 
a similar SNP of the SUR1 gene in our community 
and its relationship with type 2 DM. We also inves-
tigated the association of this SNP with obesity in 
type 2 diabetic patients, based on the fact that obesity 
is common in type 2 diabetes that make us wonder 
about a possible intersection of genetic predispo-
sitions caused by polymorphisms in metabolic or 
regulatory genes.
MATERIALS AND METHODS
Subjects
The subjects were selected from Izmir, the third big-
gest city in Turkey which reflects the ethnical prop-
erties of the west of Turkey. 90 patients (45 males 
and 45 females, aged 43-70 years old) who were 
followed up in the diabetes outpatient clinic were 
enrolled in the study. The patients were diagnosed 
according  to  the  American  Diabetes  Association 
(ADA) criteria. And, the patients given lipid-lower-
ing therapy during the last six months, and have any 
disease that could affect lipid levels, were exclud-
ed from the study. Totally 80 age and sex matched 
healthy volunteers (39 males and 41 females, aged 
45-70 years old) who did not have a family history 
of diabetes were included in the study as a control 
group after ruling out diseases which could diag-
nosed clinically and biochemically. Informed con-
sent was obtained from each subject before partici-
pation.
Samples
Blood samples were drawn into vacutainer tubes 
between 08:00-09:30 am after 12 hours fasting. For 
serum separation, the blood samples were collected 
in gel-containing tubes and then centrifuged at 5000 
rpm for 10 minutes and all samples were stored at 
-20ºC until analysis. For whole blood, we used the 
tubes with EDTA, and lithium heparin to prevent 
coagulation. Obtained DNAs were studied immedi-
ately by molecular methods.
Biochemical parameters
Glucose,  triglyceride  and  cholesterol  levels  were 
spectrophotometrically  assayed  with  Olympus 
AU5200 (Tokyo, Japan). HbA1c was measured by 
turbidimetric method with Technicon RA-XT au-
toanalyzer (Technicon Corp., New York, USA).
DNA extraction
Genomic DNA was extracted from peripheral blood 
samples  by  standard  procedures.  G’NOME  DNA 
isolation kit (BIO 101, Joshua Way, CA, USA) was 
used. The method to detect the SNP in blood de-
rived DNA was completely the same as previously 
described (Reis et al., 2000). The SNPs in exons 
31 were examined by a polymerase chain reaction/
restriction  fragment  length  polymorphism  (PCR-
RFLP) based method in which the exons were num-O. Evliyaoğlu et al. SUR1 gene, type 2 diabetes and obesity 163
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bered starting from the 3’ end instead of the 5’ end of 
the SUR1 gene. The SNP in exon 31 was examined 
by PCR-RFLP with primers 5’-gtagaacagggtcctgtg-
gc- 3’(forward) and 5’-tgtctccagtgacgaaggtg-3’ (re-
verse). PCR conditions were: an initial denaturation 
at 95°C for 5 min and 30 cycles at 95°C for dena-
turation, 60°C for annealing, and 72°C for exten-
sion, each step lasting 45 s, with a final extension 
for 7 min at 72°C. Amplification yielded a 250-bp 
fragment that, for the G allele, contained three BslI 
restriction sites at base pairs 53, 118, and 119 from 
the 5’ end of the forward primer. The sequence vari-
ation in the A allele abolished the consecutive Bsll 
sites at positions 118 and 119. PCR products were 
subjected to enzymatic digestion with BslI (New 
England Biolabs) and resolved on 2.0% agarose gel 
electrophoresis.  These  genotyping  patterns  were 
confirmed by sequencing the DNA extracted from 
the gel bands of two carriers of each genotype (GG, 
GA, and AA).
Statistical analysis
Student’s t-test was used to compare quantitative 
data between the DM and the control groups. Geno-
type and allelic frequencies among the groups of the 
study were compared by Chi-Square test. Subjects 
were compared according to their SUR1 genotype 
for differences in clinical and biochemical data by 
Kruskal-Wallis test and Mann-Whitney’s test. Chi-
Square test was performed in the analysis of asso-
ciations between classified variables. All analyses 
were performed using the SPSS version 13.0 soft-
ware. P values of <0.05 were considered to be sta-
tistically significant.
RESULTS
The clinical and biochemical characteristics of the 
study subjects are shown in Table 1. There was no 
statistically significant difference between the DM 
and the control groups for age and gender. The PCR 
product was 250 bp in length. For the G allele, 250 
bp fragment contained three Bsll restriction sites 
and,  after  digestion,  generated  fragment  sizes  of 
132 bp, 65 bp, 52 bp and 1 bp (not seen on the gel) 
(Figure 1). The sequence variation in the A allele 
cancelled the consecutive Bsll sites at base pairs 118 
and 119. Therefore, the A allele presented a pattern 
of 198 and 52 bp. Genotype and allele frequency 
distribution of exon 31 SNP of the SUR1 gene in 
diabetic patients and controls are shown in Table 2. 
A significantly higher frequency of the A allele was 
found in type 2 DM patients compared with that of 
the control group (41% vs. 24%, χ2=10.8, P<0.01), 
and this association was stronger in the subgroup 
of  patients  with  obesity  (A  allele  44%,  χ2=11.5, 
P<0.01).
The AA genotype (21% vs. 7.5%, P=0.01) and 
the  combined AA/AG  genotypes  (60%  vs.  40%, 
P=0.009) were more prevalent in diabetic than in 
control  subjects.  In  addition,  this  tendency  was 
also observed in patients with obesity (AA 24%, 
P=0.007, and AA/AG 64%, P=0.015 compared with 
controls), but no significant difference was found 
between non-obese patients and controls (AA 18%, 
P=0.12, and AA/AG 56%, P=0.13).
Figure 1. Restriction fragments.O. Evliyaoğlu et al. SUR1 gene, type 2 diabetes and obesity 164
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As an association study of a SNP in the SUR1 
gene  (AGG→AGA;  Arg1273Arg),  the  patients 
bearing at least one A allele (AA+AG; n=54) had 
significantly  higher  triglyceride  levels  (229  ±  68 
vs. 186 ± 59, P<0.05), and had a higher frequency 
of family history of diabetes but the difference was 
not significant (P=0.13), than the patients without 
the A allele (GG; n=36). However, in patients with 
diabetes, there were no significant differences be-
tween different genotypes of the SUR1 gene poly-
morphism regarding fasting glucose, HbA1c, total 
cholesterol, disease duration, age of onset, presence 
of diabetic complications and oral anti-diabetic or 
insulin therapy (data not shown).
Table 1. Clinical and biochemical characteristics of the subjects.
Control group Patients with BMI<25a Patients with BMI≥30a p
Subjects (n) 80 45 45 N.S.
Age (years) 56 (45-70) 55 (43-68) 57 (44-70) N.S.
Sex (male-female) 39-41 22-23 23-22 N.S.
Length (m) 1.65 (1.55-1.80) 1.66 (1.56-1.78) 1.62 (1.50-1.82) N.S.
Weight (kg) 69 (58-83) 60 (52-75) 88 (68-115) N.S.
Family history (%) - 49 62 N.S.
Duration of disease (years) - 9.2 (1-18) 11.4 (2-22) N.S.
Age of diagnosis of disease (years) - 48 (41-54) 46 (39-53) N.S.
Complicated patients (%) - 35 42 N.S.
Treatment (Insulin ± OAD-OAD) - 25%-75% 38%-62% N.S.
Fasting glucose (mg/dl)  88 (69-112) 158 (118-255) 185 (123-314) <0.001
HbA1c (%) 5.2 (4.1-6.6) 8.8 (5.6-13.3) 9.7 (5.9-14.2) <0.001
Total cholesterol (mg/dl) 170 (125-232) 182 (128-265) 235 (170-298) <0.001
Triglycerides (mg/dl) 135 (58-245) 138 (66-278) 277 (145-383) <0.001
Data are expressed as mean and range; a (kg/m2); BMI, body mass index; OAD, oral anti-diabetic agents.
Table 2. Genotypic and allelic distribution of exon 31 R1273R SNP of the SUR1 gene among type 2 DM patients and 
control subjects.
Controls (n=80) All patients (n=90) Patients with BMI<25 a (n=45) Patients with BMI≥30 a (n=45)
Genotypes
GG 48 (60%) 36 (40%) 20 (44%) 16 (36%)
GA 26 (32.5%) 35 (39%) 17 (38%) 18 (40%)
AA 6 (7.5%) 19 (21%) 8 (18%) 11 (24%)
P.value 0.01 0.12 0.007
Alleles
G 122 (76%) 107 (59%) 57 (63%) 50 (56%)
A 38 (24%) 73 (41%) 33 (37%) 40 (44%)
P.value 0.001 0.03 0.001
Data are expressed as number of subjects (percentage); a (kg/m2); NS, no significant difference; P values as compared 
with control subjects.O. Evliyaoğlu et al. SUR1 gene, type 2 diabetes and obesity 165
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DISCUSSION
It has been shown that the pancreatic beta-cell KATP 
channel activity is impaired as a result of functional 
mutations of SUR1 or Kir6.2 subunits, leads to un-
controlled oversecretion of insulin despite severe 
hypoglycemia.13,14  Therefore,  SUR1  and  Kir6.2 
genes have been suspected to be involved in the im-
paired insulin secretion in type 2 DM.
The mechanism of SUR1 polymorphism in hy-
perglycemia is revealed by studies on insulin secre-
tion and insulin sensitivity in different genotypes.15,17 
Our study reports that the SNP in exon 31 of the 
SUR1 gene is strongly associated with type 2 DM in 
Turkish patients. This result favors previous studies 
and gives potent evidence for the role of SUR1 gene 
in the etiology of the disease. We have observed an 
increased frequency of the A allele in exon 31 of 
the SUR1 gene in the case of type 2 DM, and it is 
noteworthy that this association was stronger in the 
subgroup of patients with obesity.
The relationship between SNPs of the SUR1 
gene  and  type  2  DM  has  been  demonstrated  in 
many communities but different alleles or differ-
ent SNPs were found to be related with type 2 DM 
in each community. The SNPs in intron 15 splice 
acceptor  site  (IVS15-3c→t;  cagGCC→tagGCC), 
exon  18  (ACC→ACT;  Thr759Thr)  and  exon  31 
(AGG→AGA; Arg1273Arg) of the SUR1 gene have 
been found to be related with type 2 DM in different 
populations.18,19 Despite these reports, it has been 
shown that SUR1 mutations impairing KATP chan-
nel activity do not appear to be major determinants 
of type 2 DM susceptibility in Japanese.20 Allelic 
variation in the SUR1 gene plays a critical role in 
insulin secretion defect in type 2 DM etiology (Ash-
croft et al., 1999). The A allele of a SNP in exon 31 
of the SUR1 gene (AGG→AGA; Arg1273Arg) has 
previously been shown to be associated with hyper-
insulinemia in nondiabetic Mexican-American sub-
jects.11 This led to a study on probable SNPs on the 
same gene in French type 2 DM patients. In that 
study, as in ours, the A allele found to be associated 
with type 2 DM.12 The association reported in the 
same study was stronger in the subgroup of patients 
with age of diagnosis of diabetes equal to or less 
than 45 years. In this group of patients, allele and 
genotype frequencies were found to be similar in 
obese and nonobese subjects, while an association 
between the A allele and diabetes was observed only 
in nonobese subjects in the group of patients with 
age of diagnosis of diabetes in the second and third 
terciles of the distribution. Conversely, in our study, 
the association between the A allele and diabetes 
was stronger in obese type 2 DM patients, which 
indicates the presence of multiple genes in the etiol-
ogy and differences in environmental factors.
We also found that the patients bearing at least 
one A  allele  had  significantly  higher  triglyceride 
levels, and had a higher frequency of family history 
of  diabetes  (not  significant  statistically)  than  the 
patients without the A allele. Type 2 DM and obe-
sity are frequently associated and share metabolic 
abnormalities, and obesity, especially android-type 
of obesity is also found to be a risk factor for type 
2 DM.21,22 This phenotypic risk factor needs to be 
inspected genotypically. In addition, the hyperin-
sulinemia might result from an initial defect of the 
pancreatic beta-cell KATP channels and may con-
tribute to the excess of fat deposition and to the de-
velopment of insulin resistance.23,24 Taken together, 
these results suggest that the genes encoding key 
components of insulin secretion pathways can be 
considered as candidate genes not only for type 2 
DM but also for obesity, and may point an intersec-
tion in the metabolic pathways. The possible effect 
of the SUR variants on obesity has not been evalu-
ated clearly. Variations in the SUR genes could con-
tribute to hyperglycemia and weight gain in indi-
viduals at high risk for obesity and type 2 DM. It has 
been reported that the exon 22 T variant of the SUR 
gene was associated with obesity and type 2 DM, 
and an indication of linkage between the SUR re-
gion and obesity was found in French Caucasians.8 
These  observations  accentuate  the  importance  of 
the complex interactions between obesity and type 
2 DM. The genes encoding Kir6.2 and SUR1 sub-
units are located 4.5 kb apart on the human chro-
mosome 11p15.1 .4 Moreover, it is noteworthy that 
the human chromosomal region 11p15 also harbors 
the human homolog of the tubby locus, which is re-
sponsible for hyperinsulinemia and severe obesity 
in mice.25 It has been also reported that the region 
on the short arm of chromosome 11 (11p15) shows 
suggestive evidence for linkage to obese type 2 dia-
betes, which also harbors the SUR1 gene.26,27 On the 
other hand, it is noteworthy that human adipocytes 
express SUR1 that regulates intracellular Ca+2 and, 
consequently, exerts coordinate control over lipo-
genesis and lipolysis, suggesting a potential role for O. Evliyaoğlu et al. SUR1 gene, type 2 diabetes and obesity 166
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the human adipocyte SUR1 in modulating energy 
storage and thereby potentially contributing to obe-
sity.28
In our study, the patients with SNP in the SUR1 
gene (AGG→AGA; Arg1273Arg) had significantly 
higher triglyceride levels than the patients without 
SNP, support the hypothesis that SUR1 has a po-
tential role in mediating lipogenesis and lipolysis 
in the adipocytes. However, another study showed 
that SUR2B is expressed in human adipose tissue, 
whereas SUR1 was not detected.28 It seems to be 
that the SUR locus may contribute to genetic sus-
ceptibility to obesity-induced insulin resistance and 
type 2 DM, and this contribution is not only based 
on alteration in insulin secretion but also based on 
an extrapancreatic role of the SUR. In conclusion, 
we have observed that the SNP in exon 31 of the 
SUR1 gene is strongly associated with type 2 dia-
betes mellitus in Turkish patients with concomitant 
obesity.
Our  findings  and  other  reports  indicate  the 
complex interactions between type 2 DM and obe-
sity. Variations in the SUR gene could contribute to 
fatty acid deposition, weight gain, and hyperglyce-
mia and insulin resistance by alteration of insulin 
secretion and mediating lipogenesis and lipolysis 
in extrapancreatic tissues in individuals at high risk 
for type 2 DM and obesity. The interactions of SUR 
variants with insulin secretion, insulin sensitivity, 
glucose tolerance, and especially with obesity are 
required to investigate properly in larger popula-
tions.
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